Current development in isoprenoid precursor biosynthesis and regulation. Current Opinion in Chemical Biology, 2013, s. 571–579. DOI: 10.1016/j.cbpa.2013.06.020. PMID 23891475.
Isoprenoid metabolism as a therapeutic target in gram-negative pathogens. Current Topics in Medicinal Chemistry, 2010, s. 1858–71. DOI: 10.2174/156802610793176602. PMID 20615187.
eduprofipharm.sk
CENIGA, Peter. Chronická žilová / venózna insuficiencia - profil ochorenia a základy farmakologickej terapie s dôrazným prihliadnutím na potenciál prírodných látok [online]. [Cit. 2022-05-02]. Dostupné online.
nih.gov
ncbi.nlm.nih.gov
Current development in isoprenoid precursor biosynthesis and regulation. Current Opinion in Chemical Biology, 2013, s. 571–579. DOI: 10.1016/j.cbpa.2013.06.020. PMID 23891475.
Isoprenoid metabolism as a therapeutic target in gram-negative pathogens. Current Topics in Medicinal Chemistry, 2010, s. 1858–71. DOI: 10.2174/156802610793176602. PMID 20615187.